mode百度云100as
百度云100as 时间:2021-01-04 阅读:()
58HongKongMedJVol16No1#Supplement1#February2010Beta1subunit–dependentmodulationofBKchannelbymembranecholesterolWWu,CPLau,HFTse,GRLiDepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThelargeconductanceCa2+-activatedK+(BKorMaxi-K)channelsareubiquitouslyexpressedindifferenttissueswithout(brain,liver,etc)orwith(smoothmuscleandheart)regulatorybeta-subunit,andplayanimportantroleinregulatingvariousphysiologicalprocessessuchascellexcitability,hormonesecretion,vascularactivity,etc.
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
HostWebis：美国/法国便宜服务器,100Mbps不限流量,高配置大硬盘,$44/月起
hostwebis怎么样?hostwebis昨天在webhosting发布了几款美国高配置大硬盘机器，但报价需要联系客服。看了下该商家的其它产品，发现几款美国服务器、法国服务器还比较实惠，100Mbps不限流量，高配置大硬盘，$44/月起，有兴趣的可以关注一下。HostWebis是一家国外主机品牌，官网宣称1998年就成立了，根据目标市场的不同，以不同品牌名称提供网络托管服务。2003年，通过与W...
Megalayer（159元 ）年付CN2优化带宽VPS
Megalayer 商家我们还算是比较熟悉的，商家主要业务方向是CN2优化带宽、国际BGP和全向带宽的独立服务器和站群服务器，且后来也有增加云服务器（VPS主机）业务。这次中秋节促销活动期间，有发布促销活动，这次活动力度认为还是比较大的，有提供香港、美国、菲律宾的年付VPS主机，CN2优化方案线路的低至年付159元。这次活动截止到10月30日，如果我们有需要的话可以选择。第一、特价限量年付VPS主...
6元虚拟主机是否值得购买
6元虚拟主机是否值得购买？近期各商家都纷纷推出了优质便宜的虚拟主机产品，其中不少6元的虚拟主机，这种主机是否值得购买，下面我们一起来看看。1、百度云6元体验三个月（活动时间有限抓紧体验）体验地址：https://cloud.baidu.com/campaign/experience/index.html?from=bchPromotion20182、Ucloud 10元云主机体验地址：https:...
百度云100as为你推荐
-
cm域名注册什么是CM域名？.cm .cm域名linux主机linux主机有什么区别？求答案租服务器我想租一个服务器，越便宜越好已备案域名查询已经有个顶级域名，怎么查询是否备案？域名服务商域名服务商所属区域怎么填写国内ip代理求一些国内《ip代理》地址大全国内ip代理全国各省代理IP免费网站空间哪里有永久免费的网站空间？虚拟主机软件虚拟主机管理软件那个最好用？天津虚拟主机天津APP开发的比较专业的公司有哪些?